Browsing Tag
PRIOH-1
1 post
Phase 3 analysis positions pritelivir as novel oral option for severe HSV in HIV
Phase 3 data position pritelivir as a novel oral option for severe HSV in HIV. Discover what this means for AiCuris and the antiviral market.